IPP&T Magazine Online
News

New animal feed trial shows encouraging results


January 29, 2018  


Print this page

BioAmber Inc. has announced the results of an independent commercial trial conducted with a North American feed formulator on the effectiveness of BioAmber’s Bio-Succinic Acid, BIO-SA™, as an ingredient in animal feed for nursery pigs.

The study – co-sponsored by BioAmber – BIO-SA™ feed supplementation demonstrated substantial benefits towards the growth performance and gut health in nursery pigs under dietary and environmental challenges.

Specifically, the addition of bio-succinic acid to feed resulted in material increases in the average daily weight gain of nursery pigs.

“Animal feed represents an extremely large market opportunity for BioAmber, and these studies show that our product could play an important role in antibiotic replacement,” said BioAmber CEO Richard Eno. “BIO-SA™ can assist the Animal Feed industry’s continued move away from antibiotics as well as its ongoing drive for enhanced feed productivity, while at the same time improving the overall sustainability of the supply chain. Formulation and early stage market testing continues as we move towards ongoing, commercial sales in this important sector.”

In another series of studies, in vitro tests have confirmed that BIO-SA™ exhibits antimicrobial activity against certain microorganisms at lower concentrations than other organic acids. Results obtained by BioAmber indicate that BIO-SA™ in feed additives could improve overall growth performance and reduce detrimental animal health conditions.

Succinic acid is listed by The Association of American Feed Control Officials (AAFCO) and the European Union Register of Feed Additives, for immediate use in animal feed formulations.

BioAmber’s technology platform combines biotechnology and catalysis to convert renewable feedstock into building block materials that are used in a wide variety of everyday products including plastics, paints, textiles, food additives and personal care products.

(BioAmber Inc.)